GLAXF - GlaxoSmithKline plc
| Previous close | 20.18 |
| Open | 20.79 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 20.30 - 20.79 |
| 52-week range | 14.96 - 24.20 |
| Volume | 831 |
| Avg. volume | 18,260 |
| Market cap | 103.151B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 41.01 |
| EPS (TTM) | 0.50 |
| Earnings date | N/A |
| Forward dividend & yield | 0.93 (4.57%) |
| Ex-dividend date | 14 May 2020 |
| 1y target est | N/A |
- Fool.co.uk
Forget gold and Bitcoin. I’d buy these 2 crashing UK shares today to make a million
These two UK shares have fallen in the stock market crash and could offer much better return prospects than gold or Bitcoin in my view.The post Forget gold and Bitcoin. I’d buy these 2 crashing UK shares today to make a million appeared first on The Motley Fool UK.
- Fool.co.uk
FTSE 100 shares are cheap! I believe investing in an ISA in July may help you retire rich
July may be a good time to start investing in relatively cheap FTSE 100 (INDEXFTSE: UKX) shares through a Stocks and Shares ISA.The post FTSE 100 shares are cheap! I believe investing in an ISA in July may help you retire rich appeared first on The Motley Fool UK.
- Reuters
GSK says within weeks of resubmitting HIV injection Cabenuva
GlaxoSmithKline's HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva to U.S. drug regulators, ViiV's head of research said on Thursday. ViiV executive Kimberly Smith told a media briefing that the company would stick to its previous guidance of refiling the request around mid-year and that this would happen "within weeks".
- Fool.co.uk
I think the GlaxoSmithKline share price could help you retire early
Invest in GlaxoSmithKline now and you could benefit from a share price recovery, driven by increased sales, profits and a generous quarterly dividend. The post I think the GlaxoSmithKline share price could help you retire early appeared first on The Motley Fool UK.
- Fool.co.uk
Top British stocks for July 2020
We asked our freelance writers to share their top British stocks for July including Prudential, BAE Systems, and Crest Nicholson.The post Top British stocks for July 2020 appeared first on The Motley Fool UK.
- Zacks
GlaxoSmithKline (GSK) Stock Moves -1.39%: What You Should Know
GlaxoSmithKline (GSK) closed at $40.55 in the latest trading session, marking a -1.39% move from the prior day.
- Stockopedia
Stock market volatility: Here's a large-cap worth a closer look
Shares in Glaxosmithkline (LON:GSK) are currently trading at 1633.8 but the question for investors is how much the market chaos of 2020 will impact on its pric...
- Fool.co.uk
Don’t know what stocks to buy? I’d buy cheap FTSE 100 shares in an ISA
Stocks are trading at rock-bottom prices right now. But investor tension means that many are resisting the urge to buy in. Here I look at two FTSE 100 stocks that are too cheap to miss.The post Don't know what stocks to buy? I’d buy cheap FTSE 100 shares in an ISA appeared first on The Motley Fool UK.
- Yahoo Finance UK
Coronavirus: Markets rise on vaccine hopes and lockdown easing in England
French drugmaker Sanofi said it hoped a potential vaccine could be signed off sooner than expected.
- Reuters
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated. Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021. "We are being guided by our dialogue with regulatory authorities," Sanofi research chief John Reed told reporters, when asked about the accelerated time frame.
- Zacks
The Zacks Analyst Blog Highlights: AbbVie, Oracle, GlaxoSmithKline, Kroger and Southern
The Zacks Analyst Blog Highlights: AbbVie, Oracle, GlaxoSmithKline, Kroger and Southern
- Zacks
Glaxo's Partner Begins Phase I Study on Coronavirus Vaccine
Glaxo (GSK) has several collaborations to make its pandemic adjuvant technology available to partners who are making adjuvanted COVID-19 vaccine candidates.
- Fool.co.uk
I think these are the best UK shares to buy for beginner investors
If you're new to investing and want to profit from the stock market crash, these could be the best UK shares to buy now, says Roland Head.The post I think these are the best UK shares to buy for beginner investors appeared first on The Motley Fool UK.
- Reuters
GSK in quest to be best, not first, in race for COVID-19 vaccine
There is a notable name missing from the frontrunners in the race to test experimental immunisations against the novel coronavirus: the world's largest vaccine maker GlaxoSmithKline <GSK.L>. The company laid out plans in May to produce 1 billion doses of the efficacy boosters for COVID-19 shots next year, compared to the 700 million or so vaccine doses against a range of diseases it usually produces in a year.
- Zacks
GlaxoSmithKline (GSK) Gains As Market Dips: What You Should Know
GlaxoSmithKline (GSK) closed at $41.10 in the latest trading session, marking a +0.37% move from the prior day.
- Zacks
Top Analyst Reports for AbbVie, Oracle & GlaxoSmithKline
Top Analyst Reports for AbbVie, Oracle & GlaxoSmithKline
- Zacks
Pharma Stock Roundup: FDA Approvals to MRK, LLY, NVS and GSK's Drugs
FDA approves expanded labels of Merck (MRK), Novartis (NVS) and Glaxo (GSK) drugs and Lilly's (LLY) new insulin.
- Zacks
Glaxo (GSK) HIV Drug Tivicay Gets FDA Approval for Toddlers
FDA approves Glaxo's (GSK) oral suspension formulation of its three-drug regimen for HIV, Tivicay, as a treatment for patients aged at least four weeks and weighing at least 3kg.
- Fool.co.uk
Neil Woodford completely ditched this FTSE 100 stock, but I’d happily buy it today!
The FTSE 100 fell nearly 6% last week, its biggest fall in three months. Meanwhile, this top share combines a 5% yearly payout with future growth.The post Neil Woodford completely ditched this FTSE 100 stock, but I'd happily buy it today! appeared first on The Motley Fool UK.
- Yahoo Finance UK
Coronavirus: AstraZeneca signs deal to make vaccine for Europe
AstraZeneca reached an agreement with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of a COVID-19 vaccine.
- Zacks
GlaxoSmithKline (GSK) Gains But Lags Market: What You Should Know
GlaxoSmithKline (GSK) closed the most recent trading day at $40.42, moving +0.52% from the previous trading session.
- Motley Fool
3 Stocks You Can Buy and Hold Forever
These stocks can diversify your portfolio, minimize your risk, and provide you with great long-term returns.
- Zacks
Drugmakers Target Coronavirus Vaccine in 2020: 4 Stocks in Focus
Several drugmakers have started ramping up production, anticipating huge demand if the candidates prove successful.
- Fool.co.uk
Here’s how I’d invest £200 per month in an ISA starting right now
Want to get involved in the market recovery? Here’s how I’d invest in growth and income shares in an ISA. The post Here's how I'd invest £200 per month in an ISA starting right now appeared first on The Motley Fool UK.
- Fool.co.uk
Have £1k to invest today? I’d buy these 2 FTSE 100 shares in an ISA in this stock market crash
These two FTSE 100 (INDEXFTSE:UKX) shares could offer defensive appeal during what may prove to be a challenging period for investors, in my opinion.The post Have £1k to invest today? I’d buy these 2 FTSE 100 shares in an ISA in this stock market crash appeared first on The Motley Fool UK.
